Is the new coronavirus keeping patients from seeking medical attention?

Researchers examining chloroquine (CQ), an antimalarial medication often suggested as a potential treatment for COVID-19, ended their study early over fears that patients were at an increased risk of significant heart complications.

One cardiologist is sharing his own experience with the new coronavirus to try and help others understand it can be beaten. 

The ongoing COVID-19 pandemic has resulted in massive changes for healthcare providers all over the world. A new survey explores that impact on cardiology in great detail. 

“If the devices haven’t been properly validated for accuracy, treatment decisions could be based on incorrect information.”

Treating coronary artery disease (CAD) in patients with type 2 diabetes (T2D) may require a more aggressive treatment approach than normal, according to a new scientific statement from the American Heart Association (AHA).

Some middle-aged women may think they have waited too long to reduce their risk of stroke by adopting a healthier lifestyle—that it is too late for such a change to make an impact.

The American Medical Association (AMA) has published two new documents designed to help physicians affected by the ongoing COVID-19 pandemic.

Women are at an increased risk of adverse events following percutaneous coronary intervention (PCI), according to new findings published in the Journal of the American College of Cardiology.